Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

23.3%

28 terminated/withdrawn out of 120 trials

Success Rate

65.0%

-21.5% vs industry average

Late-Stage Pipeline

13%

16 trials in Phase 3/4

Results Transparency

65%

34 of 52 completed trials have results

Key Signals

21 recruiting34 with results10 terminated18 withdrawn

Enrollment Performance

Analytics

N/A
50(50.5%)
Phase 1
16(16.2%)
Phase 2
11(11.1%)
Phase 4
10(10.1%)
Early Phase 1
6(6.1%)
Phase 3
6(6.1%)
99Total
N/A(50)
Phase 1(16)
Phase 2(11)
Phase 4(10)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (120)

Showing 20 of 120 trials
NCT05537220Phase 3Active Not Recruiting

Oral N-acetylcysteine for Retinitis Pigmentosa

Role: collaborator

NCT07325227Phase 4Not Yet Recruiting

Study of Remimazolam for Cataract Surgery

Role: collaborator

NCT06971276Completed

Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening

Role: lead

NCT06753916Phase 2Recruiting

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

Role: lead

NCT06024668Not ApplicableTerminated

Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision

Role: lead

NCT06875609Recruiting

ctDNA in Cutaneous Squamous Cell Carcinoma

Role: lead

NCT06289491Not ApplicableRecruiting

A Trial of Hydrus Microstent Versus Goniotomy

Role: lead

NCT06926478Phase 1Not Yet Recruiting

Subconjunctival Humira for Boston Keratoprosthesis

Role: lead

NCT04149210Phase 3Completed

FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial

Role: lead

NCT04827147Not ApplicableActive Not Recruiting

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

Role: lead

NCT04175938Phase 1Withdrawn

Assessment of Corneal Endothelial Function Following Hypoxic Stress

Role: lead

NCT07383701Phase 2Not Yet Recruiting

Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema

Role: lead

NCT04321954Phase 2Active Not Recruiting

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Role: lead

NCT06688578Not ApplicableRecruiting

Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait

Role: lead

NCT04735263Phase 2Recruiting

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

Role: lead

NCT04311606Phase 2Completed

Anti-VEGF Therapy for Acute Thyroid Eye Disease

Role: lead

NCT07302373Not ApplicableWithdrawn

Closed-loop Rehabilitation for Hyperactive Hearing

Role: lead

NCT05145946Not ApplicableWithdrawn

Tracking Biomarkers of Speech Intelligibility

Role: lead

NCT03079999Phase 2Active Not Recruiting

Study of Aspirin in Patients With Vestibular Schwannoma

Role: lead

NCT02441777Not ApplicableNot Yet Recruiting

Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging

Role: collaborator